|
Mahendra G. Shah, Ph.D.
Executive-in-Residence
Mahendra G. Shah, Ph.D. is a highly successful pharmaceutical
entrepreneur and executive. From September 2005 to December 2009, he
was the founder, chairman and CEO of NextWave Pharmaceuticals, a
pediatric focused specialty pharmaceutical company. From 1993 to May
2003 he was the chairman and CEO of First Horizon Pharmaceuticals, a
publicly traded specialty pharmaceutical company, where he raised
over $200 million and built a very profitable company before it was
was sold to Shionogi Pharmaceuticals for $1.4 billion. From 1991 to
October 1999, he was vice president of E. J. Financial Enterprises,
inc., which manages a fund that invests in healthcare companies. He
previously served on the boards of Unimed Pharmaceuticals (UMED),
Introgen Therapeutics (INGN), Inpharmakon, Protomed, Structural
Bioinformatics, and Zarix. From 1987 to 1991 he was the senior
director of new business development with Fujisawa USA (Astellas).
Prior to that time he worked in various scientific and management
positions with Schering-Plough and Bristol Myers-Squibb. Dr. Shah
received his Ph.D. in industrial pharmacy from St. John’s University
and his Bachelor’s and Master’s Degree in Pharmacy from L.M. College
of Pharmacy in Gujarat, India. |
Our Team
Dr. Frank Kung
Dr. Edgar G. Engleman
Dr. Albert Cha
Dr. Chen Yu
James Huang, MBA
James Zhao, MD, MBA
Mahendra Shah, Ph.D.
|
